A, D. P., RJ, G., JC, F., JG, M., ES, Z., BM, E., . . . PM, R. (2022). Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. The New England journal of medicine, 387(21), 1923. https://doi.org/10.1056/NEJMoa2210645
Chicago Style (17th ed.) CitationA, Das Pradhan, et al. "Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk." The New England Journal of Medicine 387, no. 21 (2022): 1923. https://doi.org/10.1056/NEJMoa2210645.
MLA (9th ed.) CitationA, Das Pradhan, et al. "Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk." The New England Journal of Medicine, vol. 387, no. 21, 2022, p. 1923, https://doi.org/10.1056/NEJMoa2210645.
Warning: These citations may not always be 100% accurate.